JS-K, a nitric oxide-releasing prodrug, modulates ß-catenin/TCF signaling in leukemic Jurkat cells: evidence of an S-nitrosylated mechanism. [electronic resource]
Producer: 20101105Description: 1641-9 p. digitalISSN:- 1873-2968
- Apoptosis -- drug effects
- Azo Compounds -- pharmacology
- Basic Helix-Loop-Helix Leucine Zipper Transcription Factors -- physiology
- Growth Inhibitors -- pharmacology
- Humans
- Jurkat Cells
- Nitric Oxide -- metabolism
- Nitroso Compounds -- pharmacology
- Piperazines -- pharmacology
- Precursor T-Cell Lymphoblastic Leukemia-Lymphoma -- drug therapy
- Prodrugs -- pharmacology
- Signal Transduction -- drug effects
- Transcription Factor 4
- Transcription Factors -- physiology
- Wnt Proteins -- physiology
- beta Catenin -- physiology
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural
There are no comments on this title.
Log in to your account to post a comment.